*When coverage criteria are met.
More people living with heart failure may have access to the CardioMEMS HF System
If you have heart failure, the CardioMEMS™ HF System—designed for pulmonary artery pressure monitoring— has received expanded insurance coverage. Medicare and Medicare Advantage will cover the CardioMEMS HF System for more heart failure patients, including those previously denied, when coverage criteria are met.*
Work with your care team to determine if you are a candidate for the CardioMEMS HF System.
The CardioMEMS HF System helps monitor your pressures before you experience symptoms that may impact your health1
To get a first-hand perspective about being remotely monitored, you can speak one-on-one with someone living with heart failure, like Beth, whose life has improved by using the CardioMEMS HF System.
Looking to the Future: Beth’s CardioMEMS HF System Story**
What You Can Do To Get Started:
Contact Your
Care Team
Speak with your care team to help determine if you may be a candidate for the CardioMEMS HF System. They can reach out to Abbott if they have questions about our expanded coverage.
Receive Prior Authorization
Your care team will work with you and your insurance to determine the appropriate paperwork needed to get started. If you have Medicare, no prior authorization is needed, but prior authorization is still needed for Medicare Advantage plans.
Take a proactive role in managing your heart failure with the CardioMEMS HF System
These materials are not intended to replace your doctor's advice or information. For any questions or concerns you may have regarding the medical procedures, devices and/or your personal health, please discuss these with your physicians.
*When coverage criteria is met.
**This testimonial relates an account of an individual’s response to the treatment. The patient’s account is genuine, typical and documented. However, it does not provide any indication, guide, warranty or guarantee as to the response other persons may have to the treatment. Responses to the treatment discussed can and do vary and are specific to the individual patient.
References
- Brugts JJ, Radhoe SP, Clephas PRD, et al. Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial. The Lancet. 2023;401(10394):2113-2123. doi:10.1016/S0140-6736(23)00923-6.
MAT-2503995 v2.0
Stay Connected